Page 221 - Biobehavioral Resilence to Stress
P. 221

198                                Biobehavioral Resilience to Stress

                                These publicly available databases gave us direct access to informa-

                             tion about genetic variations that reside in different parts of each gene and

                             also  identify some properties of those variations that suggest physiological

                             importance. This information, which we summarize in Table 8.1, allows
                             the researcher to consider how many variations are located in transcription
                             factor (“trans fac”) binding sites and thus are likely to aff ect gene expres-
                             sion; how many variations are located in exon–intron boundaries and other

                             relevant positions that might influence gene splicing (“splice”) and thus
                             protein formation; and how many variations are located in coding regions
                             that create amino acid substitutions (“ns cSNPs”) and thus are likely to
                             influence protein structure.


                             Pharmacological Studies and the Exploitation
                             of Genetic Network Information

                             In the effort to identify genes that mediate a complex phenotype such as

                             PTSD, researchers can leverage existing pharmacologic knowledge about

                             biochemical pathways of known or putative relevance. This approach may
                             also provide additional insight into factors that influence response to specifi c


                             treatments. In fact, the field of pharmacogenetics itself is based on the notion
                             that it is possible to identify inherited DNA variations, which infl uence indi-
                             vidual responses to particular drugs or treatments (see also PharmGKB at
                             www.pharmgkb.org; Weber, 1997).
                                Table 8.2 presents a list of studies relevant to the administration of tyro-

                             sine, which has been shown to influence both animal and human responses
                             to stress, as well as cognitive and physiologic functional abilities in the face
                             of various types of stressors (Deijen, 2005).
                                Tyrosine is known to play a critical role in the biosynthesis and ulti-
                             mate release of catecholamines (Lieberman, 2003) and can be administered
                             to combat negative effects of stress (Banderet & Lieberman, 1989; Brady,

                             Brown & Thrumond, 1980; Dollins, Krock, Storm, Wurtman & Leiberman,

                             1995; Lieberman, et al., 1984; Lieberman, Georgelis, Maher & Yeghiayan,
                             2005; Magill et al., 2003; Schurleff , Thomas, Ahlers & Schrot, 1993; Shukitt-


                             Hale, Stillman & Leiberman, 1996; Shurleff , Thomas, Schrot, Kowalski &
                               Harford, 1994; Waters et al., 2003; Yeghiayan, Luo, Shukitt-Hale & Leiber-
                             man, 2001). The gene encoding tyrosine hydroxylase (TH) is involved in


                             tyrosine production. Therefore, variation in the TH gene might infl uence
                             the ability of the cell to generate and utilize tyrosine, which in turn might

                             also affect catecholamine production. Recently, Zhang et al. (2004) iden-

                             tified a number of naturally occurring variations in the TH gene, some
                             of which were shown to influence blood pressure and catecholaminergic

                             response to stress. It is of great interest then to determine whether TH gene






                                                                                             1/22/2008   9:36:20 PM
                    CRC_71777_Ch008.indd   198                                               1/22/2008   9:36:20 PM
                    CRC_71777_Ch008.indd   198
   216   217   218   219   220   221   222   223   224   225   226